Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster dose of DTPw-HBV/Hib Kft vaccine in infants
NCT00332566Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Primary completion
- Oct 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of Zilbrix + Hib vaccine in hepatitis B (HBV), pertussis, Tetanus and 2 more, sponsored by GSK. Primary endpoint: Anti-polyribosyl-ribitol-phosphate antibody concentration. Started Jun 2006; status: completed.
02
Drugs
Zilbrix + Hib vaccine
03
Conditions
hepatitis B (HBV)pertussisTetanusHaemophilus influenzae type b infection (Hib)diphtheria
Beyond the preview
Go deeper on NCT00332566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332566.